Skip to main content

Advertisement

SpringerLink
Log in

Neuroadaptations to chronic exposure to drugs of abuse: Relevance to depressive symptomatology seen across psychiatric diagnostic categories

  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

Depressive symptomatology is expressed across a wide spectrum of psychiatric disorders including major depression and schizophrenia. Further, depressive symptomatology is also observed in individuals undergoing withdrawal from chronic exposure to various drugs of abuse including cocaine, amphetamine and nicotine. The negative affective state associated with drug withdrawal is phenomenonologically similar to that observed in depressed and schizophrenia patients suggesting that common underlying pathophysiological deficits may be involved in the depressive symptomatology seen across these different psychiatric disorders. The aim of the present review is to examine clinical and preclinical evidence in support of common neurobiological substrates mediating the negative affect associated with different psychiatric illnesses. First, clinical and epidemiological data are presented demonstrating the high comorbidity between nicotine and psychostimulant dependence, and depression or schizophrenia. It is hypothesized that drug use may represent an attempt to self-medicate an underlying negative affective state present in depressed and schizophrenia patients. Second, preclinical findings are presented that demonstrate common neurochemical deficits in drug withdrawal and depression. Taken together, these clinical and preclinical data support the hypothesis that common neurobiological substrates may mediate the depressive state observed across psychiatric diagnostic categories. Therefore, it is proposed that the study of drug-induced depressions in laboratory animals may have heuristic value in identifying the mechanisms underlying the depressive symptomatology associated not only with drug withdrawal but also major depression and schizophrenia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Acri, J.B., Brown, K.J., Saah, M.I. and Grunberg, N.E. (1995) “Strain and age differences in acoustic startle responses and effects of nicotine in rats”, Pharmacol. Biochem. Behav. 50, 191–198.

    Article  PubMed  CAS  Google Scholar 

  • Allen, A.R., Singh, A., Zhuang, Z.P., Kung, M.P., Kung, H.F. and Lucki, I. (1997) “The 5-HT1A receptor antagonist p-MPPI blocks responses mediated by postsynaptic and presynaptic 5-HT1A receptors”, Pharmacol. Biochem. Behav. 57, 301–307.

    Article  PubMed  CAS  Google Scholar 

  • American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders IV (American Psychiatric Press, Washington DC).

    Google Scholar 

  • Angrist, B., Rotrosen, J. and Gershon, S. (1980) “Differential effects of amphetamine and neuroleptics on negative and positive symptoms in schizophrenia”, Psychopharmacology 72, 17–19.

    Article  PubMed  CAS  Google Scholar 

  • Angrist, B., Peselow, E., Rubenstein, M., Corwin, J. and Rotrosen, J. (1982) “Partial improvement in negative schizophrenic symptoms after amphetamine”, Psychopharmacology 78, 128–130.

    Article  PubMed  CAS  Google Scholar 

  • Ascher, J.A., Cole, J.O., Colin, J.-N., Feighner, J.P., Ferris, R.M., Fibiger, H.C., Golden, R.N., Martin, P., Potter, W.Z., Richelson, E. and Sulser, F. (1995) “Bupropion: a review of its mechanisms of antidepressant activity”, J. Clin. Pharmacol. 56, 395–401.

    CAS  Google Scholar 

  • Aubin, H.J., Tilikete, S. and Barrucand, D. (1996) “Depression and smoking”, Encephale 22, 17–22.

    PubMed  CAS  Google Scholar 

  • Baker, G.B. and Greenshaw, A.J. (1989) “Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system”, Cell. Mol. Neurobiol. 9, 1–44.

    Article  PubMed  CAS  Google Scholar 

  • Baldo, B.A., Koob, G.F. and Markou, A. (1999) “Role of adenosine A2 receptors in brain stimulation reward under baseline conditions and during cocaine withdrawal in rats”, J. Neurosci. 19, 11017–11026.

    PubMed  CAS  Google Scholar 

  • Binder, R.L., Kazamatsuri H., Nishimura, T. and McNiel, D.E. (1987) “Smoking and tardive dyskinesia”, Biol. Psychiatry 22, 1280–1282.

    Article  PubMed  CAS  Google Scholar 

  • Blier, P. and de Montigny, C. (1994) “Current advances and trends in the treatment of depression”, Trends Pharmacol. Sci. 15, 220–226.

    Article  PubMed  CAS  Google Scholar 

  • Bokstrom, K. and Balldin, J. (1992) “A rating scale for assessment of alcohol withdrawal psychopathology (AWIP)”, Alcohol Clin. Exp. Res. 16, 241–249.

    Article  PubMed  CAS  Google Scholar 

  • Borowski, T.B. and Kokkinidis, L. (1992) “Long-term influence of d-amphetamine on mesolimbic brain-stimulation reward: comparison to chronic haloperidol and naloxone effects”, Pharmacol. Biochem. Behav. 43, 1–15.

    Article  PubMed  CAS  Google Scholar 

  • Breslau, N., Kilbey, M.M. and Andreski, P. (1993) “Nicotine dependence and major depression: New evidence from a prospective investigation”, Arch. Gen. Psychiatry 50, 31–35.

    PubMed  CAS  Google Scholar 

  • Breslau, N., Peterson, E.L., Schultz, L.R., Chilcoat, H.D. and Andreski, P. (1998) “Major depression and stages of smoking. A longitudinal investigation”, Arch. Gen. Psychiatry 55, 161–166.

    Article  PubMed  CAS  Google Scholar 

  • Buckley, P., Thompson, P., Way, L. and Meltzer, H.Y. (1994) “Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy”, Am. J. Psychiatry 151, 385–389.

    PubMed  CAS  Google Scholar 

  • Caldecott-Hazard, S. and Schneider, L.S. (1992) “Clinical and biochemical aspects of depressive disorders: III. Treatment and controversies”, Synapse 10, 141–168.

    Article  PubMed  CAS  Google Scholar 

  • Carboni, E., Bortone, L., Giua, C. and DiChiara, G. (2000) “Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats”, Drug Alcohol Depend. 58, 93–102.

    Article  PubMed  CAS  Google Scholar 

  • Carton, S., Jouvent, R. and Widlocher, D. (1994) “Nicotine dependence and motives for smoking in depression”, J. Subst. Abuse 6, 67–76.

    Article  PubMed  CAS  Google Scholar 

  • Carton, S., Le Houezec, J., Lagrue, G. and Jouvent, R. (2000) “Relationships between sensation seeking and emotional symptomatology during smoking cessation with nicotine patch therapy”, Addict. Behav. 25, 653–662.

    Article  PubMed  CAS  Google Scholar 

  • Cassens, G., Actor, C., Kling, M. and Schildkraut, J.J. (1981) “Amphetamine withdrawal: effects on threshold of intracranial reinforcement”, Psychopharmacology 73, 318–322.

    Article  PubMed  CAS  Google Scholar 

  • Cesarec, Z. and Nyman, A.K. (1985) “Differential response to amphetamine in schizophrenia”, Acta Psychiatr. Scand. 71, 523–538.

    Article  PubMed  CAS  Google Scholar 

  • Claghorn, J., Honigfeld, G., Abuzzahab, F.S., Wang, R., Steinbook, R., Tuason, V. and Klerman, G. (1987), “The risks and benefits of clozapine versus chloropromazine”, J. Clin. Psychopharmacol. 7, 377–384.

    Article  PubMed  CAS  Google Scholar 

  • Corrigall, W.A. and Coen, K.M. (1991) “Selective dopamine antagonists reduce nicotine self-administration”, Psychopharmacology 104, 171–176.

    Article  PubMed  CAS  Google Scholar 

  • Cuffel, B.J. (1992) “Prevalence estimates of substance abuse in schizophrenia and their correlates”, J. Nerv. Ment. Dis. 180, 589–592.

    Article  PubMed  CAS  Google Scholar 

  • Curzon, P., Kim, D.J. and Decker, M.W. (1994) “Effect of nicotine, lobeline, and mecamylamine on sensory gating in the rat”, Pharmacol. Biochem. Behav. 49, 877–882.

    Article  PubMed  CAS  Google Scholar 

  • Dalack, G.W., Glassman, A.H., Rivelli, S., Covey, L. and Stetner, F. (1995) “Mood, major depression, and fluoxentine response in cigarette smokers”, Am. J. Psychiatry 152, 398–403.

    PubMed  CAS  Google Scholar 

  • Dalack, G.W., Healy, D.J. and Meador-Woodruff, J.H. (1998) “Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings”, Am. J. Psychiatry 155, 1490–1501.

    PubMed  CAS  Google Scholar 

  • Dalack, G.W., Becks, L., Hill, E., Pomerleau, O.F. and Meador-Woodruff, J.H. (1999) “Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia”, Neuropsychopharmacology 21, 195–202.

    Article  PubMed  CAS  Google Scholar 

  • Decina, P., Caracci, G., Sandik, R., Berman, W., Mukherjee, S. and Scapicchio, P. (1990) “Cigarette smoking and neuroleptic-induced parkinsonism”, Biol. Psychiatry 28, 502–508.

    Article  PubMed  CAS  Google Scholar 

  • Desai, N.G., Gangadhar, B.N., Pradhan, N. and Channabasavanna, S.M. (1984) “Treatment of negative schizophrenia with d-amphetamine.” Am. J. Psychiatry 141, 723–724.

    PubMed  CAS  Google Scholar 

  • Diwan, A., Castine, M., Pomerleau, C.S., Meador-Woodruff, J.H. and Dalack, G.W. (1998) “Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders”, Schizophr. Res. 33, 113–118.

    Article  PubMed  CAS  Google Scholar 

  • Dixon, L., Haas, G., Weiden, P., Sweeney, J. and Frances, A. (1990) “Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports”, Schizophr. Bull. 16, 69–79.

    PubMed  CAS  Google Scholar 

  • Dixon, L., Haas, G., Weiden, P., Sweeney, J. and Frances, A.J. (1991) “Drug abuse in schizophrenic patients: clinical correlates and reasons for use”, Am. J. Psychiatry 148, 224–230.

    PubMed  CAS  Google Scholar 

  • Edwards, G. (1990) “Withdrawal symptoms and alcohol dependence: fruitful mysteries”, Br. J. Addict. 85, 447–461.

    Article  PubMed  CAS  Google Scholar 

  • El Yacoubi, M., Ledent, C., Parmentier, M., Bertorelli, R., Ongini, E., Costentin, J. and Vaugeois, J.-M. (2001) “Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice”, Br. J. Pharmacol. 134, 68–77.

    Article  PubMed  Google Scholar 

  • Ellenbroek, B.A. and Cools, A.R. (2000) “Animal models for the negative symptoms of schizophrenia”, Behav. Pharmacol. 11, 223–233.

    PubMed  CAS  Google Scholar 

  • Epping-Jordan, M.P., Watkins, S.S., Koob, G.F. and Markou, A. (1998) “Dramatic decreases in brain reward function during nicotine withdrawal”, Nature 393, 76–79.

    Article  PubMed  CAS  Google Scholar 

  • Esposito, R.U. and Kornetsky, C. (1977) “Morphine lowering of self-stimulation thresholds: lack of tolerance with long-term administration”, Science 195, 189–191.

    Article  PubMed  CAS  Google Scholar 

  • Fechner, G.T. (1966) In: Adler, H.E., Howes, D.H. and Boring, E.G., translators Elements of Psychophysics (Holt, Rinehart and Winston, New York) Vol. 1.

    Google Scholar 

  • Feighner, J.P., Meredith, C.H., Stern, W.C., Hendrickson, G. and Miller, L.L. (1984) “A double-blind study of bupropion and placebo in depression”, Am. J. Psychiatry 141, 525–529.

    PubMed  CAS  Google Scholar 

  • Ferry, L.H. and Burchette, R.J. (1994) Evalution of Buproprion Versus Placebo for Treatment of Nicotine Dependence (American Psychiatric Association New Research, Washington DC), pp 199–200.

    Google Scholar 

  • Frank, R.A., Manderscheid, P.Z., Panicker, S., Williams, H.P. and Kokoris, D. (1992) “Cocaine euphoria, dysphoria, and tolerance assessed using drug-induced changes in brain-stimulation reward”, Pharmacol. Biochem. Behav. 42, 771–779.

    Article  PubMed  CAS  Google Scholar 

  • Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., Rosenthal, J., Waldo, M.C., Reimherr, F., Wender, P., Yaw, J., Young, D.A., Breese, C.R., Adams, C., Patterson, D., Adler, L.E., Kruglyak, L., Leonard, S. and Byerley, W. (1997) “Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus”, Proc. Natl Acad. Sci. USA 94, 587–592.

    Article  PubMed  CAS  Google Scholar 

  • Fryer, J.D. and Lukas, R.J. (1999) “Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine”, J. Pharmacol. Exp. Ther. 288, 88–92.

    PubMed  CAS  Google Scholar 

  • Fudala, P.J., Teoh, K.W. and Iwamoto, E.T. (1985) “Pharmacologic characterization of nicotine-induced conditioned place preference”, Pharmacol. Biochem. Behav. 22, 237–241.

    Article  PubMed  CAS  Google Scholar 

  • Gawin, F.H. and Kleber, H.D. (1986) “Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: clinical observations”, Arch. Gen. Psychiatry 43, 107–113.

    PubMed  CAS  Google Scholar 

  • George, T.P., Sernyak, M.J., Ziedonis, D.M. and Woods, S.W. (1995) “Effects of clozapine on smoking in chronic schizophrenic outpatients”, J. Clin. Psychiatry 56, 344–346.

    PubMed  CAS  Google Scholar 

  • Geyer, M.A. and Braff, D.L. (1987) “Startle habituation and sensorimotor gating in schizophrenia and related animal models”, Schizophr. Bull. 13, 643–668.

    PubMed  CAS  Google Scholar 

  • Geyer, M.A. and Markou, A. (1995) “Animal models of psychiatric disorders”, In: Bloom, F.E. and Kupfer, D.J., eds, Psychopharmacology: The Fourth Generation of Progress (Raven Press, New York), pp 787–798.

    Google Scholar 

  • Geyer, M.A. and Markou, A. (2002) “The role of preclinical models in the development of psychotropic drugs”, In: Charney, D., Coyle, J., Davis, K. and Nemeroff, C., eds, Psychopharmacology: The Fifth Generation of Progress (Lippincott/Williams and Wilkins, Philadelphia/Baltimore), pp. 445–455.

    Google Scholar 

  • Glassman, A.H. (1993) “Cigarette smoking: implications for psychiatric illness”, Am. J. Psychiatry 150, 546–553.

    PubMed  CAS  Google Scholar 

  • Glassman, A.H., Stetner, F. and Walsh, B.T. (1988) “Heavy smokers, smoking cessation and clonidine: results of a double-blind, randomized trial”, J. Am. Med. Assoc. 259, 2863–2866.

    Article  CAS  Google Scholar 

  • Glassman, A.H., Helzer, J.E., Covey, L.S., Cottler, L.B., Stetner, F., Tipp, J.E. and Johnson, J. (1990) “Smoking, smoking cessation, and major depression”, J. Am. Med. Assoc. 264, 1546–1549.

    Article  CAS  Google Scholar 

  • Glowinski, J. and Axelrod, J., (1964) “Inhibition of uptake of tritiated-noradrenaline in the intact rat brain by imipramine and structurally related compounds”, Science 204, 1318–1319.

    CAS  Google Scholar 

  • Glynn, S.M. and Sussman, S. (1990) “Why patients smoke”, Hosp. Community Psychiatry 41, 1027–1028.

    PubMed  CAS  Google Scholar 

  • Goff, D.C., Henderson, D.C. and Amico, E. (1992) “Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects”, Am. J. Psychiatry 149, 1189–1194.

    PubMed  CAS  Google Scholar 

  • Goldberg, S.R. and Henningfield, J.E. (1988) “Reinforcing effects of nicotine in humans and experimental animals responding under intermittent schedules of i.v. drug injection”, Pharmacol. Biochem. Behav. 30, 227–234.

    Article  PubMed  CAS  Google Scholar 

  • Goldberg, S.R., Spealman, R.D. and Goldberg, D.M. (1981) “Persistent behavior at high rates maintained by intravenous self-administration of nicotine”, Science 214, 573–575.

    Article  PubMed  CAS  Google Scholar 

  • Goodwin, D.W. (1992) “Alcohol: clinical aspects”, In: Lowinson, J.H., Ruiz, P., Millman, R.B. and Langrod, J.G., eds, Substance Abuse: A Comprehensive Textbook (Williams and Wilkins, Baltimore, MD), pp. 144–151.

    Google Scholar 

  • Gosling, J.A. and Lu, T.C. (1969) “Uptake and distribution of some quaternary ammonium compounds in the central nervous system of the rat”, J. Pharmacol. Exp. Ther. 167, 56–62.

    PubMed  CAS  Google Scholar 

  • Green, A.R. (1987) “Evolving concepts on the interactions between antidepressant treatments and monoamine neurotransmitters”, Neuropharmacology 26, 815–822.

    Article  PubMed  CAS  Google Scholar 

  • Green, A.I., Zimmet, S.V., Strous, R.D. and Schildkraut, J.J. (1999) “Clozapine for comorbid substance use disorder and schizophrenia: Do patients with schizophrenia have a rewarddeficiency syndrome that can be ameliorated by clozapine?”, Harvard Res. Psychiatry 6, 287–296.

    Article  CAS  Google Scholar 

  • Haertzen, C.A. and Hooks, Jr., N.T. (1969) “Changes in personality an subjective experience associated with the chronic administration and withdrawal of opiates”, J. Nerv. Ment. Dis. 148, 606–614.

    PubMed  CAS  Google Scholar 

  • Hall, R.G., Duhamel, M., McClanahan, R., Miles, G., Nason, C., Rosen, S., Schiller, P., Tao-Yonenaga, L. and Hall, S.M. (1995) “Level of functioning, severity of illness, and smoking status among chronic psychiatric patients”, J. Nerv. Ment. Dis. 183, 468–471.

    PubMed  CAS  Google Scholar 

  • Harrison, A.A., Liem, Y.T. and Markou, A. (2001) “Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats”, Neuropsychopharmacology 25, 55–71.

    Article  PubMed  CAS  Google Scholar 

  • Henningfield, J.E. and Goldberg, S.R. (1983) “Nicotine as a reinforcer in human subjects and laboratory animals”, Pharmacol. Biochem. Behav. 19, 989–992.

    Article  PubMed  CAS  Google Scholar 

  • Henningfield, J.E., Johnson, R.E. and Jasinski, D.R. (1987) “Clinical procedures for the assessment of abuse potential”, In: Bozarth, M.A., eds, Methods of Assessing the Reinforcing Properties of Abused Drugs (Springer, New York), pp 573–590.

    Google Scholar 

  • Hildebrand, B.E., Nomikos, G.G., Bondjers, C., Nisell, M. and Svensson, T.H. (1997) “Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms”, Psychopharmacology 129, 348–356.

    Article  PubMed  CAS  Google Scholar 

  • Hildebrand, B.E., Panagis, G., Svensson, T.H. and Nomikos, G.G. (1999) “Behavioral and biochemical manifestations of mecamy-lamine-precipitated nicotine withdrawal in the rat: role of nicotinic receptors in the ventral tegmental area”, Neurosychopharmacology 21, 560–574.

    Article  CAS  Google Scholar 

  • Hughes, J.R. (1992) “Tobacco withdrawal in self-quitters”, J. Consult. Clin. Psychol. 60, 689–697.

    Article  PubMed  CAS  Google Scholar 

  • Hughes, J.R. (1993) “Possible effects of smoke-free inpatient units on psychiatric diagnosis and treatment”, J. Clin. Psychiatry 54, 109–114.

    PubMed  CAS  Google Scholar 

  • Hughes, J.R. (1996) “The future of smoking cessation therapy in the United States”, Addiction 91, 1797–1802.

    Article  PubMed  CAS  Google Scholar 

  • Hughes, J.R. and Hatsukami, D. (1992) “The nicotine withdrawal syndrome: a brief review and update”, Int. J. Smoking Cessation 1, 21–26.

    Google Scholar 

  • Hughes, J.R., Hatsukami, D.K., Pickens, R.W., Krahn, D., Malin, S. and Luknic, A. (1984) “Effect of nicotine on the tobacco withdrawal syndrome”, Psychopharmacology 83, 82–87.

    Article  PubMed  CAS  Google Scholar 

  • Hughes, J.R., Hatsukami, D.K., Mitchell, J.E. and Dahlgren, L.A. (1986) “Prevalence of smoking among psychiatric outpatients”, Am. J. Psychiatry 143, 993–997.

    PubMed  CAS  Google Scholar 

  • Hughes, J.R., Gust, S.W., Skoog, K., Keenan, R.M. and Fenwick, J.W. (1991) “Symptoms of tobacco withdrawal: a replication and extension”, Arch. Gen. Psychiatry 48, 52–59.

    PubMed  CAS  Google Scholar 

  • Hughes, J.R., Higgins, S.T. and Bickel, W.K. (1994) “Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities”, Addiction 89, 1461–1470.

    Article  PubMed  CAS  Google Scholar 

  • Hurt, R.D., Sachs, D.P.L., Glover, E.D., Offord, K.P., Johnston, J.A., Dale, L.C., Khayrallah, M.A., Schroeder, D.R., Glover, P.N., Sullivan, C.R., Croghan, I.T. and Sullivan, P.M. (1997) “A comparison of sustained-release buproprion and placebo for smoking cessation”, N. Engl. J. Med. 337, 1195–1202.

    Article  PubMed  CAS  Google Scholar 

  • Huston-Lyons, D. and Kornetsky, C. (1992) “Effects of nicotine on the threshold for rewarding brain stimulation in rats”, Pharmacol. Biochem. Behav. 41, 755–759.

    Article  PubMed  CAS  Google Scholar 

  • Isola, R., Vogelsberg, V., Wemlinger, T.A., Neff, N.H. and Hadjiconstantinou M. (1999) “Nicotine abstinence in the mouse”, Brain Res. 850, 189–196.

    Article  PubMed  CAS  Google Scholar 

  • Jaffe, J.H. (1990) “Drug addiction and drug abuse”, In: Goodman Gilman, A., Rall, T.W., Nies, A.S. and Taylor, P., eds, Goodman's and Gilman's The Pharmacological Basis of Therapeutics, 8th ed. (Pergamon Press, Elmsford, New York), pp 522–573.

    Google Scholar 

  • Jarvik, M.E. (1991) “Beneficial effects of nicotine”, Br. J. Addict. 86, 571–575.

    Article  PubMed  CAS  Google Scholar 

  • Jibson, M.D. and Tandon, R. (1998) “New atypical antipsychotic medications”, J. Psychiatr. Res. 32, 215–228.

    Article  PubMed  CAS  Google Scholar 

  • Jorenby, D.E., Leischow, S.J., Nides, M.A., Rennard, S.I., Johnston, J.A., Hughes, A.R., Smith, S.S., Muramoto, M.L., Daughton, D.M., Doan, K., Fiore, M.C. and Baker, T.B. (1999) “A controlled trial of sustained-release buproprion, a nicotine patch, or both for smoking cessation”, N. Engl. J. Med. 340, 685–691.

    Article  PubMed  CAS  Google Scholar 

  • van Kammen, D.P. and Boronow, J.J. (1988) “Dextro-amphetamine diminishes negative symptoms in schizophrenia”, Int. Clin. Psychopharmacol. 3, 111–121.

    Article  PubMed  Google Scholar 

  • Kendler, K.S., Neale, M.C., MacLean, C.J., Heath, A.C., Eaves, L.J. and Kessler, R.C. (1993) “Smoking and major depression: a causal analysis”, Arch. Gen. Psychiatry 50, 36–43.

    PubMed  CAS  Google Scholar 

  • Kessler, R.C., McGonagle, K.A., Zhao, S., Nelson, C.B., Hughes, M., Eshleman, S., Wittchen, H.U. and Kendler, K.S. (1994) “Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey”, Arch. Gen. Psychiatry 51, 8–19.

    PubMed  CAS  Google Scholar 

  • Khantzian, E.J. (1985) “The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence”, Am. J. Psychiatry 142, 1259–1264.

    PubMed  CAS  Google Scholar 

  • Khantzian, E.J. (1997) “The self-medication hypothesis of substance use disorders: a reconsideration and recent applications”, Harv. Rev. Psychiatr. 4, 231–244.

    Article  CAS  Google Scholar 

  • Knights, A. and Hirsch, S.R. (1981) “Revealed' depression and drug treatment for schizophrenia”, Arch. Gen. Psychiatry 38, 806–811.

    PubMed  CAS  Google Scholar 

  • Kokkinidis, L. and McCarter, B.D. (1990) “Postcocaine depression and sensitization of brain stimulation reward: analysis of reinforcement and performance effects”, Pharmacol. Biochem. Behav. 36, 463–471.

    Article  PubMed  CAS  Google Scholar 

  • Kokkinidis, L. and Zacharko, R.M. (1980a) “Enhanced lateral hypothalamic self-stimulation responding after chronic exposure to amphetamine”, Behav. Neural Biol. 29, 493–497.

    Article  PubMed  CAS  Google Scholar 

  • Kokkinidis, L. and Zacharko, R.M. (1980b) “Response sensitization and depression following long-term amphetamine treatment in a self-stimulation paradigm”, Psychopharmacology 68, 73–76.

    Article  PubMed  CAS  Google Scholar 

  • Kokkinidis, L., Zacharko, R.M. and Predy, P.A. (1980) “Postamphetamine depression of self-stimulation responding from the substantia nigra: reversal by tricyclic antidepressants”, Pharmacol. Biochem. Behav. 13, 379–383.

    Article  PubMed  CAS  Google Scholar 

  • Kokkinidis, L., Zacharko, R.M. and Anisman, H. (1986) “Amphetamine withdrawal: a behavioral evaluation”, Life Sci. 38, 1617–1623.

    Article  PubMed  CAS  Google Scholar 

  • Koob, G.F., Markou, A., Weiss, F. and Schulteis, G. (1993) “Opponent process and drug dependence: Neurobiological mechanisms”, Semin. Neurosci. 5, 351–358.

    Article  Google Scholar 

  • Kornetsky, C. and Esposito, R.U. (1981) “Reward and detection thresholds for brain stimulation: dissociative effects of cocaine”, Brain Res. 209, 496–500.

    Article  PubMed  CAS  Google Scholar 

  • Kornetsky, C., Markowitz, R.A. and Esposito, R.U. (1981) “Phencyclidine and naloxone: effects on sensitivity to aversive and rewarding stimulation in the rat”, In: Domino, E.F., eds, PCP (Phencyclidine): Historical and Current Perspectives (NPP Books, Ann Arbor), pp 321–330.

    Google Scholar 

  • Krystal, J.H., D'Souza, D.C., Madonick, S. and Petrakis, I.L. (1999) “Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients”, Schizophr. Res. 35(Suppl.), S35-S49.

    Article  PubMed  Google Scholar 

  • Kumari, V., Checkley, S.A. and Gray, J.A. (1996) “Effect of cigarette smoking on prepulse inhibition of the acoustic startle reflex in healthy male smokers”, Psychopharmacology 128, 54–60.

    Article  PubMed  CAS  Google Scholar 

  • LeDuc, P.A. and Mittleman, G. (1995) “Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence”, Psychopharmacology 121, 407–427.

    Article  PubMed  CAS  Google Scholar 

  • Leith, N.J. and Barrett, R.J. (1976) “Amphetamine and the reward system: evidence for tolerance and post-drug depression”, Psychopharmacologia 46, 19–25.

    Article  PubMed  CAS  Google Scholar 

  • Leith, N.J. and Barrett, R.J. (1980) “Effects of chronic amphetamine or reserpine on self-stimulation responding: animal model of depression?”, Psychopharmacology 72, 9–15.

    Article  PubMed  CAS  Google Scholar 

  • de Leon, J., Dadvand, M., Canuso, C., White, A.O., Stanilla, J.K. and Simpson, G.M. (1995) “Schizophrenia and smoking: and epidemiological survey in a state hospital”, Am. J. Psychiatry 152, 453–455.

    PubMed  Google Scholar 

  • Lin, D., Koob, G.F. and Markou, A. (1999) “Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat: Interactions between the two drugs”, Psychopharmacology 145, 283–294.

    Article  PubMed  CAS  Google Scholar 

  • Lysaker, P., Bell, M., Beam-Goulet, J. and Milstein, R. (1994) “Relationship of positive and negative symptoms to cocaine abuse in schizophrenia”, J. Nerv. Ment. Dis. 182, 109–112.

    Article  PubMed  CAS  Google Scholar 

  • Malin, D.H., Lake, J.R., Newlin-Maultsby, P., Roberts, L.K., Lanier, J.G., Carter, V.A., Cunningham, J.S. and Wilson, O.B. (1992) “Rodent model of nicotine abstinence syndrome”, Pharmacol. Biochem. Behav. 43, 779–784.

    Article  PubMed  CAS  Google Scholar 

  • Malin, D.H., Lake, J.R., Carter, V.A., Cunningham, J.S., Hebert, K.M., Conrad, D.L. and Wilson, O.B. (1994) “The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat”, Psychopharmacology 115 180–184.

    Article  PubMed  CAS  Google Scholar 

  • Malin, D.H., Lake, J.R., Schopen, C.K., Kirk, J.W., Sailer, E.E., Lawless, B.A., Upchurch, T.P., Shenoi, M. and Rajan, N. (1997) “Nicotine abstinence syndrome precipitated by central but not peripheral hexamethonium”, Pharmacol. Biochem. Behav. 58, 695–699.

    Article  PubMed  CAS  Google Scholar 

  • Malin, D.H., Lake, J.R., Upchurch, T.P., Shenoi, M., Rajan, N. and Schweinle, W.E. (1998) “Nicotine abstinence syndrome precipitated by the competitive nicotinic antagonist dihydro-β-erythroidine”, Pharmacol. Biochem. Behav. 60, 609–613.

    Article  PubMed  CAS  Google Scholar 

  • Marcus, P. and Snyder, R. (1995) “Reduction of comorbid substance abuse with clozapine”, Am. J. Psychiatry 152, 959.

    PubMed  CAS  Google Scholar 

  • Marder, S.R., Wirshing, W.C. and Van Putten, T. (1991) “Durg treatment of schizophrenia: Overview of recent research”, Schizophr. Res. 4, 81–90.

    Article  PubMed  CAS  Google Scholar 

  • Markou, A. and Koob, G.F. (1991) “Post-cocaine anhedonia: an animal model of cocaine withdrawal”, Neuropsychopharmacology 4, 17–26.

    PubMed  CAS  Google Scholar 

  • Markou, A. and Koob, G.F. (1992a) “Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations”, Physiol. Behav. 51, 111–119.

    Article  PubMed  CAS  Google Scholar 

  • Markou, A. and Koob, G.F. (1992b) “Bromocriptine reverses the elevation in intracranial self-stimulation thresholds observed in a rat model of cocaine withdrawal”, Neuropsychopharmacology 7, 213–224.

    PubMed  CAS  Google Scholar 

  • Markou, A. and Koob, G.F. (1993) “Intracranial self-stimulation thresholds as a measure of reward”, In: Sahgal, A., eds, Behavioural Neuroscience, A Practical Approach, (Oxford University Press, New York) Vol. 2, pp 93–115.

    Google Scholar 

  • Markou, A. and Paterson, N. (2001) “The role of α7 nicotinic receptors in nicotine self-administration and withdrawal in the rat”, Nicotine Tobacco Res., 361–373.

  • Markou, A., Hauger, R.L. and Koob, G.F. (1992) “Desmethylipramine attenuates cocaine withdrawal in rats”, Psychopharmacology 109, 305–314.

    Article  PubMed  CAS  Google Scholar 

  • Markou, A., Kosten, T.R. and Koob, G.F. (1998) “Neurobiological similarities in depression and drug dependence: a self-medication hypothesis”, Neuropsychopharmacology 18, 135–174.

    Article  PubMed  CAS  Google Scholar 

  • Masterson, E. and O'Shea, B. (1984), “Smoking and malignancy in schizophrenia”, Br. J. Psychiatry 145, 429–432.

    Article  PubMed  CAS  Google Scholar 

  • Mauskopf, J.A., David, K., Grainger, D.L. and Gibson, P.J. (1999) “Annual health outcomes and treatment costs for schizophrenia populations”, J. Clin. Psychiatry 60(Suppl. 19), 14–19.

    PubMed  Google Scholar 

  • McAskill, R., Mir, S. and Taylor, D. (1998) “Pindolol augmentation of antidepressant therapy”, Br. J. Psychiatry 173, 203–208.

    Article  PubMed  CAS  Google Scholar 

  • McEvoy, J., Freudenreich, O., McGee, M., VanderZwaag, C., Levin, E. and Rose, J. (1995) “Clozapine decreases smoking in patients with chronic schizophrenia”, Biol. Psychiatry 37, 550–552.

    Article  PubMed  CAS  Google Scholar 

  • McEvoy, J.P., Freudenreich, O. and Wilson, W.H. (1999) “Smoking and therapeutic response to clozapine in patients with schizophrenia”, Biol. Psychiatry 46, 125–129.

    Article  PubMed  CAS  Google Scholar 

  • Meltzer, H.Y. (1999) “Outcome in schizophrenia: beyond symptom reduction”, J. Clin. Psychiatry 60(Suppl. 3), 3–7.

    PubMed  Google Scholar 

  • Menza, M.A., Grossman, N., Van Horn, M., Cody, R. and Forman, N. (1991) “Smoking and movement disorders in psychiatric patients”, Biol. Psychiatry 30, 109–115.

    Article  PubMed  CAS  Google Scholar 

  • Moller, H.J. (1998) “Novel antipsychotics and negative symptoms”, Int. Clin. Psychopharmacol. 13(Suppl. 3), S43-S47.

    PubMed  Google Scholar 

  • Mueser, K.T., Yarnold, P.R., Levinson, D.F., Singh, H., Bellack, A.S., Kee, K., Morrison, R.L. and Yadalam, K.G. (1990) “Prevalence of substance abuse in schizophrenia: demographic and clinical correlates”, Schizophr. Bull. 16, 31–56.

    PubMed  CAS  Google Scholar 

  • Nunes, E.V., McGrath, P.J., Quitkin, F.M., Ocepek-Welikson, K., Stewart, J.W., Koenig, T., Wager, S. and Klein, D.F. (1995) “Imipramine treatment of cocaine abuse: possible boundaries of efficacy”, Drug Alcohol Depend. 39, 185–195.

    Article  PubMed  CAS  Google Scholar 

  • Olincy, A., Young, D.A. and Freedman, R. (1997) “Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers”, Biol. Psychiatry 42, 1–5.

    Article  PubMed  CAS  Google Scholar 

  • Parrott, A.C. (1993) “Cigarette smoking: effects upon self-rated stress and arousal over the day”, Addict. Behav. 18, 389–395.

    Article  PubMed  CAS  Google Scholar 

  • Parsons, L.H., Smith, A.D. and Justice, Jr., J.B. (1991) “Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine”, Synapse 9, 60–65.

    Article  PubMed  CAS  Google Scholar 

  • Parsons, L.H., Koob, G.F. and Weiss, F. (1995) “Serotonin dysfunction in the nucleus accumbens of rats during with-drawal after unlimited access to intravenous cocaine”, J. Pharmacol. Exp. Ther. 274, 1182–1191.

    PubMed  CAS  Google Scholar 

  • Paterson, N.E., Myers, C. and Markou, A. (2000) “Effects of repeated withdrawal from continuous amphetamine administration on brain reward function”, Psychopharmacology 152, 440–446.

    Article  PubMed  CAS  Google Scholar 

  • Patkar, A.A., Alexander, R.C., Lundy, A. and Certa, K.M. (1999) “Changing patterns of illicit substance use among schizophrenic patients: 1984–1996”, Am. J. Addict. 8, 65–71.

    Article  PubMed  CAS  Google Scholar 

  • Phillips, A.G. and Fibiger, H.C. (1989) “Neuroanatomical basis of intracranial self-stimulation reward: untangling the Gordian knot”, In: Liebman, J.M. and Cooper, S.J., eds, The Neuropharmacological Basis of Reward (Clarendon Press, Oxford), pp 66–105.

    Google Scholar 

  • Pomerleau, O., Adkins, D. and Pertschuk, M. (1978) “Predictors of outcome and recidivism in smoking cessation treatment”, Addict. Behav. 3, 65–70.

    Article  PubMed  CAS  Google Scholar 

  • Risner, M.E. and Goldberg, S.R. (1983) “A comparison of nicotine and cocaine self-administration in the dog: fixed-ratio and progressive-ratio schedules of intravenous drug infusion”, J. Pharmacol. Exp. Ther. 224, 319–326.

    PubMed  CAS  Google Scholar 

  • Robbins, A.S. (1993) “Pharmacological approaches to smoking cessation”, Am. J. Prev. Med. 9, 31–33.

    PubMed  CAS  Google Scholar 

  • Robins, L.N., Regier, D.A., eds, (1991) Psychiatric Disorders in America: The Epidemiologic Catchment Area Study (The Free Press, New York).

    Google Scholar 

  • Robins, L.N., Helzer, J.E., Weissman, M.M., Orvaschel, H., Gruenberg, E., Burke, Jr., J.D. and Regier, D.A. (1984) “Lifetime prevalence of specific psychiatric disorders in three sites”, Arch. Gen. Psychiatry 41, 949–958.

    PubMed  CAS  Google Scholar 

  • Robinson, D., Mayerhoff, D., Alvir, J., Cooper, T. and Lieberman, J. (1991) “Mood responses of remitted schizophrenics to methyl-phenidate infusion”, Psychopharmacology 105, 247–252.

    Article  PubMed  CAS  Google Scholar 

  • Romero, L., Bell, N., Casanovas, J.M. and Artigas, F. (1996) “Two actions are better than one: avoiding self-inhibition of serotonergic neurones enhances the effects of serotonin uptake inhibitors”, Int. Clin. Psychopharmacol. 11(Suppl. 4), 1–8.

    Article  PubMed  Google Scholar 

  • Rosenthal, R.N., Hellerstein, D.J. and Miner, C.R. (1994) “Positive and negative syndrome typology in schizophrenic patients with psychoactive substance use disorders”, Compr. Psychiatry 35, 91–98.

    Article  PubMed  CAS  Google Scholar 

  • Rossetti, Z.L., Hmaidan, Y. and Gessa, G.L. (1992) “Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats”, Eur. J. Pharmacol. 221, 227–234.

    Article  PubMed  CAS  Google Scholar 

  • Rounsaville, B.J., Anton, S.F., Carroll, K., Budde, D., Prusoff, B.A. and Gawin, F. (1991) “Psychiatric diagnoses of treatmentseeking cocaine abusers”, Arch. Gen. Psychiatry 48, 43–51.

    PubMed  CAS  Google Scholar 

  • Sandyk, R. (1993) “Cigarette smoking: Effects on cognitive functions and drug-induced parkinsonism in chronic schizophrenia”, Int. J. Neurosci. 70, 193–197.

    Article  PubMed  CAS  Google Scholar 

  • Sanfilipo, M., Wolkin, A., Angrist, B., van Kammen, D.P., Duncan, E., Wieland, S., Cooper, T.B., Peselow, E.D. and Rotrosen, J. (1996) “Amphetamine and negative symptoms of schizophrenia”, Psychopharmacology 123, 211–214.

    Article  PubMed  CAS  Google Scholar 

  • Satel, S.L., Price, L.H., Palumbo, J.M., McDougle, C.J., Krystal, J.H., Gawin, F., Charney, D.S., Heninger, G.R. and Kleber, H.D. (1991) “Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study”, Am. J. Psychiatry 148, 1712–1716.

    PubMed  CAS  Google Scholar 

  • Schneier, F.R. and Siris, S.G. (1987) “A review of psychoactive substance use and abuse in schizophrenia: patterns of drug choice”, J. Nerv. Ment. Dis. 175, 641–652.

    Article  PubMed  CAS  Google Scholar 

  • Schuckit, M.A., Tipp, J.E., Bergman, M., Reich, W., Hesselbrock, V.M. and Smith, T.L. (1997) “A comparison of induced and independent major depressive disorders in 2945 alcoholics”, Am. J. Psychiatry 154, 948–957.

    PubMed  CAS  Google Scholar 

  • Serper, M.R., Alpert, M., Richardson, N.A., Dickson, S., Allen, M.H. and Werner, A. (1995) “Clinical effects of recent cocaine use on patients with acute schizophrenia”, Am. J. Psychiatry 152, 1464–1469.

    PubMed  CAS  Google Scholar 

  • Sevy, S., Kay, S.R., Opler, L.A. and van Praag, H.M. (1990) “Significance of cocaine history in schizophrenia”, J. Nerv. Ment. Dis. 178, 642–648.

    Article  PubMed  CAS  Google Scholar 

  • Shiffman, S.M. and Jarvik, M.E. (1976) “Smoking withdrawal symptoms in two weeks of abstinence”, Psychopharmacology 50, 35–39.

    Article  PubMed  CAS  Google Scholar 

  • Slemmer, J.E., Martin, B.R. and Damaj, M.I. (2000) “Bupropion is a nicotinic antagonist”, J. Pharmacol. Exp. Ther. 295, 321–327.

    PubMed  CAS  Google Scholar 

  • Soni, S.D. and Brownlee, M. (1991) “Alcohol abuse in chronic schizophrenics: implications for management in the community”, Acta Psychiatr. Scand. 84, 272–276.

    Article  PubMed  CAS  Google Scholar 

  • Stellar, J. and Stellar, E. (1985) The Neurobiology of Reward and Motivation (Springer, New York).

    Google Scholar 

  • Stevens, S.S. (1951) “Mathematics measurement, and psychophysics”, In: Stevens, S., eds, Handbook of Experimental Psychology (Wiley, New York), pp 1–49.

    Google Scholar 

  • Stolerman, I.P. and Jarvis, M.J. (1995) “The scientific case that nicotine is addictive”, Psychopharmacology 117, 2–10.

    Article  PubMed  CAS  Google Scholar 

  • Tran, P.V., Hamilton, S.H., Kuntz, A.J., Potvin, J.H., Andersen, S.W., Beasley, Jr., C. and Tollefson, G.D. (1997) “Double-blind comparison of olanzapine verus risperidone in the treatment of schizophrenia and other psychotic disorders”, J. Clin. Pharmacol. 17, 407–418.

    CAS  Google Scholar 

  • Waal-Manning, H.J. and de Hamel, F.A. (1978) “Smoking habit and psychometric scores: a community study”, Z.N. Med. J. 88, 188–191.

    CAS  Google Scholar 

  • Watkins, S.S., Epping-Jordan, M.P., Koob, G.F. and Markou, A. (1999) “Blockade of nicotine self-administration with nicotinic antagonists in rats”, Pharmacol. Biochem. Behav. 62, 743–751.

    Article  PubMed  CAS  Google Scholar 

  • Watkins, S.S., Koob, G.F. and Markou, A. (2000a) “Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal”, Nicotine Tobacco Res. 2, 19–37.

    Article  CAS  Google Scholar 

  • Watkins, S.S., Stinus, L., Koob, G.F. and Markou, A. (2000b) “Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects”, J. Pharmacol. Exp. Ther. 292, 1053–1064.

    PubMed  CAS  Google Scholar 

  • Weddington, W.W., Brown, B.S., Haertzen, C.A., Cone, E.J., Dax, E.M., Herning, R.I. and Michaelson, B.S. (1990) “Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts: a controlled, residential study”, Arch. Gen. Psychiatry 47, 861–868.

    PubMed  CAS  Google Scholar 

  • Weiss, F., Markou, A., Lorang, M.T. and Koob, G.F. (1992) “Basal dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-acess self-administration”, Brain Res. 593, 314–318.

    Article  PubMed  CAS  Google Scholar 

  • West, R. and Gossop, M. (1994) “Overview: A comparison of withdrawal symptoms from different drug classes”, Addiction 89, 1483–1489.

    Article  PubMed  CAS  Google Scholar 

  • West, R.J., Jarvis, M.J., Russell, M.A., Carruthers, M.E. and Feyerabend, C. (1984) “Effect of nicotine replacement on the cigarette withdrawal syndrome”, Br. J. Addict. 79, 215–219.

    PubMed  CAS  Google Scholar 

  • Wilkins, J.N. (1997) “Pharmacotherapy of schizophrenia patients with comorbid substance abuse”, Schizophr. Bull. 23, 215–228.

    PubMed  CAS  Google Scholar 

  • Wise, R.A. and Munn, E. (1993) “Effects of repeated amphetamine injections on lateral hypothalarnic brain stimulation reward and subsequent locomotion”, Behav Brain Res. 55, 195–201.

    Article  PubMed  CAS  Google Scholar 

  • Wise, R.A. and Munn, E. (1995) “Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds”, Psychopharmacology 117, 130–136.

    Article  PubMed  CAS  Google Scholar 

  • Wise, R.A., Bauco, P., Carlezon, Jr, W.A. and Trojniar, W. (1992) “Self-stimulation and drug reward mechanisms”, Ann. N.Y. Acad. Sci. 654, 192–198.

    Article  PubMed  CAS  Google Scholar 

  • Wong, D.T., Bymaster, F.P. and Engleman, E.A. (1995) “Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication”, Life Sci. 57, 411–441.

    Article  PubMed  CAS  Google Scholar 

  • Yassa, R., Lal, S., Korpassy, A. and Ally, J. (1987) “Nicotine exposure and tardive dyskinesia”, Biol. Psychiatry 22, 67–72.

    Article  PubMed  CAS  Google Scholar 

  • Zanardi, R., Artigas, F., Franchini, L., Sforzini, L., Gasperini, M., Smeraldi, E. and Perez, J. (1997) “How long should pindolol be associated with paroxetine to improve the antidepressant response?”, J. Clin. Psychopharmacol. 17, 446–450.

    Article  PubMed  CAS  Google Scholar 

  • Ziedonis, D.M. and Kosten, T.R. (1991) “Depression as a prognostic factor for pharmacological treatment of cocaine dependence”, Psychopharmacol. Bull. 27, 337–343.

    PubMed  CAS  Google Scholar 

  • Ziedonis, D., Richardson, T., Lee, E., Petrakis, I. and Kosten, T. (1992) “Adjunctive desipramine in the treatment of cocaine abusing schizophrenics”, Psychopharmacol. Bull. 28, 309–314.

    PubMed  CAS  Google Scholar 

  • Ziedonis, D.M., Kosten, T.R., Glazer, W.M. and Frances, R.J. (1994) “Nicotine dependence and schizophrenia”, Hosp. Community Psychiatry 45, 204–206.

    PubMed  CAS  Google Scholar 

  • Zimmet, S.V., Strous, R.D., Burgess, E.S., Kohnstamm, S. and Green, A.I. (2000) “Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: A retrospective survey”, J. Clin. Pharmacol. 20, 94–98.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuropharmacology, The Scripps Research Institute, 10550 North Torrey Pines Rd, 92037, La Jolla, CA, USA

    Athina Markou & Paul J. Kenny

Authors
  1. Athina Markou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul J. Kenny
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Athina Markou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Markou, A., Kenny, P.J. Neuroadaptations to chronic exposure to drugs of abuse: Relevance to depressive symptomatology seen across psychiatric diagnostic categories. neurotox res 4, 297–313 (2002). https://doi.org/10.1080/10298420290023963

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1080/10298420290023963

Keywords

Search

Navigation